Went public 8/4/2000 at $15 per share
Filing Range: 4 mil. shares @ $13 to $15
Share Outstanding: 18.2 mil. shares
Underwriters: Bear, Stearns & Co. Inc./Chase H&Q/U.S. Bancorp Piper
Company Counsel: Morgan Lewis & Bockius
Manager Counsel: Coudert Brothers
Auditor: Richard A. Eisner & Co. LLP
Uses its DiscoverWorks technology to identify small-molecule drug candidates by using such features as protein production, high-throughput screening, a library of some 200,000 chemical compounds and 2.5 billion novel analogs and 3-D target protein structure analysis to expedite the process. The company is also developing a pipeline of cardiovascular and oncology drug candidates, which it plans to license out in the early trial stages.
MPM Asset Management LLC
Healthcare Ventures LLC
Abingworth Management Ltd.
State of Michigan Retirement Systems
Philadelphia Ventures Inc.
SENMED Medical Ventures
Aetna Life & Casualty
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 10/01/1996 2 Early Stage 5418.0
2 03/12/1997 7 Early Stage 12500.1
3 01/06/1998 2 Later Stage 10800.0
4 11/18/1999 2 Later Stage 500.0
5 03/21/2000 9 Expansion 18533.0
(Data in $ millions)
Total Revenues: $4.5
Net Income: -16.0